Share
In June, Endocrine Society members Salwa Zahalka, MD; Palak Choksi, MD; Mandy Bell, MD; and Dan Spratt, MD; who serve as the Society’s delegation to the American Medical Association’s (AMA) House of Delegates, attended the AMA meeting in Chicago to advocate for policies important to our members. The AMA House of Delegates meets twice a...
Share
Society Advocates for Access to Diabetes and Obesity Medications; Meets with FDA to Discuss Current Prescription Drug Shortages Over the past several months, the Endocrine Society has advocated for improving access to diabetes and obesity medications amid ongoing drug shortages that have impacted the country. The Society has heard from our members that they are...
Share
Endocrine Society Advocates to Protect and Increase Funding for the NIH On March 5, the Endocrine Society will conduct a Researcher Hill Day to advocate for the importance of the National Institutes of Health (NIH). We are asking Congress to complete work on a funding bill for the remainder of fiscal year (FY) 2024, before...
Share
The Endocrine Society is advocating for you. In 2023 we achieved several important advocacy accomplishments, including: All these accomplishments were achieved because our members participated in our advocacy activities, online campaigns, Hill Days, and meetings with policymakers. Below are some examples of our advocacy victories. Advocacy to Lower the Cost of Insulin – The Endocrine Society...
Share
Government Shutdown Averted for Second Time as Society Advocates to Fund Health, Research Programs With the clock running out on a federal government shutdown that was to begin midnight November 17, Congress passed a short-term bill to keep the government open. The bill will fund most health programs, including the National Institutes of Health (NIH),...
Share
The Endocrine Society continues to advocate for insulin affordability. Although new legislation to make insulin more affordable has been stalled in Congress, the Centers for Medicare and Medicaid Services (CMS) continues to advance a program to implement drug price negotiations to lower the cost of certain prescription drugs, including several diabetes medications. CMS recently hosted...
Share
In September, the federal government unveiled a list of the first 10 drugs that will undergo price negotiations between Medicare and pharmaceutical companies. Notably, four of these drugs are diabetes medications. New prices for these medicines will be announced in September 2024 and new prices will take effect on January 1, 2026, unless pharmaceutical companies...
Share
The Endocrine Society hosted a congressional briefing in September to educate members of Congress and congressional staff on anti-obesity medications. The briefing featured two Endocrine Society members who are experts in obesity medicine. Jonathan Purnell, MD, professor of medicine at Oregon Health & Science University, provided attendees with an opportunity to learn more about these...